Va. Biotech’s Stock Falls Despite Win Over Study Contractor

July 3, 2018

A biotech company developing an immunotherapy injection to help treat head and neck cancer lost ground on Wall Street even though it won a long-running dispute over a clinical trial contract.

Related Stories